Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Skin Epidermal Progenitor Maintenance by the SRCAP-H2A.Z Axis Downstream to Extracellular Signal-Regulated Kinase and mTOR Signaling.

The Journal of investigative dermatology·2025
Same author

CASZ1 Is Essential for Skin Epidermal Terminal Differentiation.

The Journal of investigative dermatology·2024
Same author

Nucleoporin downregulation modulates progenitor differentiation independent of nuclear pore numbers.

Communications biology·2023
Same author

NUP98 and RAE1 sustain progenitor function through HDAC-dependent chromatin targeting to escape from nucleolar localization.

Communications biology·2023
Same author

CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors.

Nature communications·2022
Same author

GPSmatch: an R package for comparing Genomic-binding Profile Similarity among transcriptional regulators using customizable databases.

Bioinformatics (Oxford, England)·2021

Video Experimental Relacionado

Updated: Sep 10, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

6.6K

Una mutación truncante dominante de SRCAP promueve la progresión del carcinoma de células escamosas

Stephenie H Droll1, Elena I O Dewar1, Celia Xue1

  • 1Northwestern University, Department of Molecular Biosciences, Evanston, IL, 60208, USA.

Oncogenesis
|August 26, 2025
PubMed
Resumen

Una nueva mutación SRCAP (SRCAP-1879) impulsa la progresión del cáncer epitelial, aumentando la proliferación y la invasión. Esto difiere de las mutaciones SRCAP relacionadas con el síndrome de Puerto Flotante, destacando un nuevo papel en el desarrollo del cáncer de piel.

Más Videos Relacionados

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.5K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

6.6K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.5K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K

Área de la Ciencia:

  • En el campo de la oncología
  • Biología molecular
  • La genética

Sus antecedentes:

  • Los cánceres epiteliales, incluido el carcinoma de células escamosas cutáneas (CSC), son una de las principales causas de muerte por cáncer.
  • El gen SRCAP, un remodelador de la cromatina, es frecuentemente mutado en el cSCC.
  • Se sabe que las mutaciones SRCAP causan el síndrome de Puerto Flotante (FHS), pero su papel en el CSCC es menos conocido.

Objetivo del estudio:

  • Investigar el papel de una mutación truncante específica del SRCAP (SRCAP-1879) en la patogénesis del CSCC.
  • Diferenciar los efectos de la mutación SRCAP-1879 de las mutaciones SRCAP asociadas con la FHS.

Principales métodos:

  • Análisis de las mutaciones del cSCC para identificar un truncamiento del punto caliente del SRCAP (SRCAP-1879).
  • Expresión de las truncadas SRCAP-1879 y SRCAP-FHS en un modelo cSCC y queratinocitos humanos primarios.
  • Evaluación de la proliferación, la diferenciación, la invasión, la expresión génica (MMP9) y la motilidad celular.

Principales resultados:

  • La mutación SRCAP-1879 aumentó significativamente la proliferación, deterioró la diferenciación y aceleró la invasión en los modelos de cSCC.
  • SRCAP-1879 desreguló los genes clave relacionados con el cáncer en los queratinocitos sin alterar la ocupación de H2A.Z.
  • SRCAP-1879 indujo fuertemente la expresión de MMP9 y la motilidad de los queratinocitos, a diferencia de la mutación SRCAP-FHS que redujo la motilidad.

Conclusiones:

  • La mutación truncante SRCAP-1879 juega un papel distinto y significativo en la promoción de la progresión del cáncer epitelial, en particular la invasión.
  • Este hallazgo amplía la comprensión de la función de SRCAP en el cáncer más allá de su papel conocido en FHS.
  • La orientación a MMP9 puede ofrecer estrategias terapéuticas para el cSCC impulsado por mutaciones SRCAP-1879.